Skip to main content
logo
Akeso, Inc. (HKG:9926)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
87.55
+3.65 (4.35%)
Jun 18, 2026, 4:08 PM HKT

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Research, Development, Production and Sale of Biopharmaceutical Products
3.06B2.12B4.53B837.66M225.63M
Research, Development, Production and Sale of Biopharmaceutical Products Growth
43.90%-53.08%440.35%271.26%-
Total
3.06B2.12B4.53B837.66M225.63M
Total Growth
43.90%-53.08%440.35%271.26%-

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Mainland China
2.70B1.88B1.59B837.66M97.03M
Mainland China Growth
43.78%17.85%90.24%763.33%-
United States of America (USA)
338.52M243.64M2.93B-128.60M
United States of America (USA) Growth
38.94%-91.69%---
Other Regions
17.50M2.26M1.20M--
Other Regions Growth
675.58%87.53%---
Total
3.06B2.12B4.53B837.66M225.63M
Total Growth
43.90%-53.08%440.35%271.26%-